Inference in randomized studies with informative censoring and discrete time-to-event endpoints

被引：36
|
作者：
Scharfstein, D [1 ]
Robins, JM
Eddings, W
Rotnitzky, A
机构：
[1] Johns Hopkins Sch Hyg & Publ Hlth, Dept Biostat, Baltimore, MD 21025 USA
[2] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA
[3] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
来源：
BIOMETRICS | 2001年 / 57卷 / 02期
关键词：
coarsening at random; competing risks; curse of dimensionality; inverse probability of censoring weighted estimation; Kaplan-Meier estimator; sequential ignorability of censoring;
D O I：
10.1111/j.0006-341X.2001.00404.x
中图分类号：
Q [生物科学];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
In this article. we present a method for estimating and comparing the treatment-specific distributions of a discrete time-to-event variable from right-censored data. Our method allows for (1) adjustment for informative censoring due to measured prognostic factors for time to event and censoring and (2) quantification of the sensitivity of the inference to residual dependence between time to event and censoring due to unmeasured factors. We develop our approach in the context of a randomized trial for the treatment of chronic schizophrenia. We perform a simulation study to assess the practical performance of our methodology.
引用
收藏
页码：404 / 413
页数：10
相关论文
共 50 条
  • [31] Analysis of composite time-to-event endpoints in cardiovascular outcome trials
    Marceau West, Rachel
    Golm, Gregory
    Mehrotra, Devan, V
    [J]. CLINICAL TRIALS, 2024,
  • [32] Adaptive Designs for Two Candidate Primary Time-to-Event Endpoints
    Rauch, Geraldine
    Schuler, Svenja
    Wirths, Marius
    Englert, Stefan
    Kieser, Meinhard
    [J]. STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2016, 8 (02): : 207 - 216
  • [33] Semiparametric regression for discrete time-to-event data
    Berger, Moritz
    Schmid, Matthias
    [J]. STATISTICAL MODELLING, 2018, 18 (3-4) : 322 - 345
  • [34] Validity of Tests for Time-to-Event Endpoints in Studies with the Pocock and Simon Covariate-Adaptive Randomization
    Johnson, Victoria P.
    Gekhtman, Michael
    Kuznetsova, Olga M.
    [J]. STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2023,
  • [35] Discrimination measures for discrete time-to-event predictions
    Schmid, Matthias
    Tutz, Gerhard
    Welchowski, Thomas
    [J]. ECONOMETRICS AND STATISTICS, 2018, 7 : 153 - 164
  • [36] Guidelines for the definitions of time-to-event endpoints in randomized clinical trials: Results of the DATECAN Project for Sarcomas and GISTs
    Bellera, Carine A.
    Ouali, Monia
    Penel, Nicolas
    Bonvalot, Sylvie
    Casali, Paolo Giovanni
    Delannes, Martine
    Nielsen, Ole Steen
    Mathoulin-Pelissier, Simone
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [37] Two-stage screened selection designs for randomized phase II trials with time-to-event endpoints
    Wu, Jianrong
    Pan, Haitao
    Hsu, Chia-Wei
    [J]. BIOMETRICAL JOURNAL, 2022, 64 (07) : 1207 - 1218
  • [38] Guidelines for the definitions of time-to-event endpoints in randomized clinical trials: Results of the datecan project for breast group
    Gourgou-Bourgade, S.
    Dabakuyo-Yonli, S.
    Cameron, D.
    Cardoso, F.
    Poortmans, P.
    Asselain, B.
    Azria, D.
    [J]. CANCER RESEARCH, 2013, 73
  • [39] Causal inference for time-to-event data with a cured subpopulation
    Wang, Yi
    Deng, Yuhao
    Zhou, Xiao-Hua
    [J]. BIOMETRICS, 2024, 80 (02)
  • [40] Guidelines for the definitions of time-to-event endpoints in randomized clinical trials: Results of the DATECAN Project for Breast Group
    Gourgou, Sophie
    Dabakuyo, Tienhan Sandrine
    Asselain, Bernard
    Azria, David
    Cameron, David A.
    Cardoso, Fatima
    Poortmans, Philip M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
12345